Not Rated
|
Fund Size
(0.02% of Investment in Category)
|
Expense Ratio
(0.89% Category average)
|
| Period Invested for | ₹10000 Invested on | Latest Value | Absolute Returns | Annualised Returns | Category Avg | Rank within Category |
|---|---|---|---|---|---|---|
| 1 Week | 28-Oct-25 | 10098.10 | 0.98% | - | -0.24% | 20/227 |
| 1 Month | 03-Oct-25 | 10564.70 | 5.65% | - | 2.42% | 3/227 |
| 3 Month | 04-Aug-25 | 10198.20 | 1.98% | - | 4.18% | 185/223 |
| 6 Month | 02-May-25 | 10774.90 | 7.75% | - | 10.79% | 151/213 |
| YTD | 01-Jan-25 | 10118.00 | 1.18% | - | 5.36% | 131/201 |
| Since Inception | 06-Dec-24 | 10290.00 | 2.90% | 3.18% | 14.33% | 173/199 |
| Period Invested for | ₹1000 SIP Started on | Investments | Latest Value | Absolute Returns | Annualised Returns |
|---|---|---|---|---|---|
| No Data Found | |||||
If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not included. If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 20%. Any cess/surcharge is not included in the 20%.
Top 10 Stocks in Portfolio
| Stock Invested in | Sector | Value(Mn) | % of Total Holdings | 1M Change | 1Y Highest Holding | 1Y Lowest Holding | Quantity | 1M Change in Qty |
|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | Pharmaceuticals | 128.5 | 12.26% | -0.02% | 13.47% (Dec 2024) | 0% (Oct 2024) | 80.57 k | -2.14 k |
| Divis Laboratories Ltd. | Pharmaceuticals | 88.1 | 8.40% | -0.44% | 8.84% (Aug 2025) | 0% (Oct 2024) | 15.48 k | 0.00 |
| Max Healthcare Institute Ltd. | Hospital | 77.6 | 7.40% | -0.08% | 7.94% (Jun 2025) | 0% (Oct 2024) | 69.59 k | 0.00 |
| Dr. Reddys Laboratories Ltd. | Pharmaceuticals | 67.2 | 6.41% | -0.03% | 6.52% (Dec 2024) | 0% (Oct 2024) | 54.89 k | 0.00 |
| Aster DM Healthcare Ltd. | Hospital | 63.9 | 6.09% | 0.39% | 6.09% (Sep 2025) | 0% (Oct 2024) | 1.02 L | 0.00 |
| Mankind Pharma Ltd. | Pharmaceuticals | 54.7 | 5.22% | 0.05% | 5.22% (Sep 2025) | 0% (Oct 2024) | 22.45 k | 0.00 |
| J.b. Chemicals & Pharmaceuticals Ltd. | Pharmaceuticals | 49.2 | 4.70% | 2.53% | 4.7% (Sep 2025) | 0% (Oct 2024) | 28.79 k | 15.27 k |
| Krishna Institute of Medical Sciences Ltd. | Hospital | 41 | 3.91% | -0.04% | 3.95% (Aug 2025) | 0% (Oct 2024) | 58.58 k | 0.00 |
| Abbott India Ltd. | Pharmaceuticals | 34.8 | 3.32% | -0.16% | 3.79% (Jun 2025) | 0% (Oct 2024) | 1.19 k | 0.00 |
| Global Health Ltd. | Hospital | 34.8 | 3.32% | -0.07% | 3.39% (Aug 2025) | 0% (Oct 2024) | 26.47 k | 0.00 |
| Name | Type of Instrument | Weight (%) |
|---|---|---|
| TREPS | TREPS | 1.62% |
| Net Receivables | Net Receivables | 0.08% |
Ratios calculated on daily returns for last 3 years (Updated as on 01st January, 1970)
No data available. Ratios are only available for the funds which are 3 years old.
| Scheme Name |
Crisil Rank |
Asset Size (Cr) |
1M |
3M |
6M |
1Y |
3Y |
|---|---|---|---|---|---|---|---|
| Nippon India Taiwan Equity Fund - Direct Plan - Growth | NA | 406.67 | 1.34 | 26.29 | 63.29 | 46.69 | 41.91 |
| Aditya Birla Sun Life International Equity Fund - Direct Plan - Growth | NA | 266.19 | 0.53 | 7.20 | 22.20 | 32.42 | 19.61 |
| Franklin Asian Equity Fund - Direct - Growth | NA | 279.13 | 3.89 | 14.04 | 26.62 | 24.04 | 17.95 |
| Nippon India Japan Equity Fund - Direct Plan - Growth | NA | 289.73 | 1.05 | 8.61 | 18.40 | 22.70 | 20.55 |
| HDFC Transportation and Logistics Fund - Direct Plan - Growth | NA | 1651.55 | 1.08 | 11.03 | 29.10 | 22.29 | 0.00 |
| HDFC Defence Fund - Direct Plan - Growth | NA | 7024.28 | 0.27 | 6.46 | 18.11 | 20.13 | 0.00 |
| DSP Banking & Financial Services Fund - Direct Plan - Growth | NA | 1419.62 | 4.00 | 6.90 | 10.70 | 19.63 | 0.00 |
| Quant BFSI Fund - Direct Plan - Growth | NA | 655.17 | 3.03 | 4.42 | 20.17 | 19.07 | 0.00 |
| ITI Banking and Financial Services Fund - Direct Plan - Growth | NA | 311.03 | 5.15 | 7.04 | 9.15 | 18.85 | 15.83 |
| SBI Banking & Financial Services Fund - Direct Plan - Growth | NA | 8693.07 | 3.34 | 6.04 | 10.94 | 17.69 | 20.70 |
Out of 24 mutual fund schemes offered by this AMC, 1 is/are ranked 5 * , 3 is/are ranked 4 * , 3 is/are ranked 3 * , 4 is/are ranked 2 * , 2 is/are ranked 1 * , and 11 schemes are not ranked. See more about AMC
| Scheme Name |
Crisil Rank |
Asset Size (Cr) |
1M |
3M |
6M |
1Y |
3Y |
|---|---|---|---|---|---|---|---|
| PGIM India Midcap Fund - Direct Plan - Growth | 2 | 11326.40 | 1.81 | 2.51 | 10.82 | 7.04 | 14.67 |
| PGIM India Flexi Cap Fund - Direct Plan - Growth | 2 | 6193.15 | 3.23 | 4.56 | 9.12 | 8.34 | 15.13 |
| PGIM India Global Equity Opportunities Fund of Fund - Direct Plan - Growth | NA | 1614.87 | 0.82 | 11.23 | 21.45 | 16.23 | 26.90 |
| PGIM India Small Cap Fund - Direct Plan - Growth | 3 | 1567.96 | 3.09 | 3.69 | 17.35 | 4.49 | 16.17 |
| PGIM India Balanced Advantage Fund - Direct Plan - Growth | NA | 938.46 | 2.17 | 2.73 | 5.88 | 7.23 | 12.06 |
| PGIM India Large and Midcap Fund - Direct Plan - Growth | NA | 763.24 | 2.42 | 3.39 | 8.80 | 9.99 | 0.00 |
| PGIM India ELSS Tax Saver Fund - Direct Plan - Growth | 2 | 757.48 | 3.23 | 3.49 | 6.27 | 7.43 | 14.49 |
| PGIM India Emerging Markets Equity Fund of Fund - Direct Plan - Growth | NA | 675.50 | 0.10 | 12.69 | 22.74 | 19.74 | 19.17 |
| PGIM India Large Cap Fund - Direct Plan - Growth | 3 | 592.77 | 3.06 | 4.62 | 6.43 | 8.55 | 13.71 |
| PGIM India Liquid Fund - Direct Plan - Growth | 1 | 475.45 | 0.48 | 1.46 | 3.05 | 6.82 | 7.11 |